Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$17.41
-0.31-1.75%
At close: -
$17.32
-0.09-0.52%
After Hours: 1:34 PM EDT
Comments
Loading...
ADMA Biologics (NASDAQ:ADMA) Stock, Analyst Ratings, Price Targets, Forecasts
ADMA Biologics Inc has a consensus price target of $21.25 based on the ratings of 4 analysts. The high is $26 issued by HC Wainwright & Co. on November 8, 2024. The low is $14 issued by Mizuho on June 20, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Raymond James, and HC Wainwright & Co. on November 8, 2024, November 8, 2024, and October 14, 2024, respectively. With an average price target of $23 between HC Wainwright & Co., Raymond James, and HC Wainwright & Co., there's an implied 32.79% upside for ADMA Biologics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Raymond James
Cantor Fitzgerald
Mizuho
1calculated from analyst ratings
Analyst Ratings for ADMA Biologics
Data brought to you by Benzinga APIs
FAQ
What is the target price for ADMA Biologics (ADMA) stock?
The latest price target for ADMA Biologics (NASDAQ:ADMA) was reported by HC Wainwright & Co. on November 8, 2024. The analyst firm set a price target for $26.00 expecting ADMA to rise to within 12 months (a possible 50.12% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ADMA Biologics (ADMA)?
The latest analyst rating for ADMA Biologics (NASDAQ:ADMA) was provided by HC Wainwright & Co., and ADMA Biologics maintained their buy rating.
When was the last upgrade for ADMA Biologics (ADMA)?
There is no last upgrade for ADMA Biologics
When was the last downgrade for ADMA Biologics (ADMA)?
There is no last downgrade for ADMA Biologics.
When is the next analyst rating going to be posted or updated for ADMA Biologics (ADMA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ADMA Biologics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ADMA Biologics was filed on November 8, 2024 so you should expect the next rating to be made available sometime around November 8, 2025.
Is the Analyst Rating ADMA Biologics (ADMA) correct?
While ratings are subjective and will change, the latest ADMA Biologics (ADMA) rating was a maintained with a price target of $18.00 to $26.00. The current price ADMA Biologics (ADMA) is trading at is $17.32, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.